11757714

Source:http://linkedlifedata.com/resource/pubmed/id/11757714

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0302350, umls-concept:C0679199, umls-concept:C1332225
pubmed:dateCreated	2001-12-6
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9107334
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal..., http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide, http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin, http://linkedlifedata.com/resource/pubmed/chemical/Prednisone, http://linkedlifedata.com/resource/pubmed/chemical/Vincristine, http://linkedlifedata.com/resource/pubmed/chemical/rituximab
pubmed:status	MEDLINE
pubmed:issn	0939-5555
pubmed:author	pubmed-author:German High-Grade Non-Hodgkin's Lymphoma Study Group, pubmed-author:GlassBB, pubmed-author:PfreundschuhMM, pubmed-author:SchmitsRR, pubmed-author:TrümperLL
pubmed:issnType	Print
pubmed:volume	80 Suppl 3
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	B77-83
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:11757714-Adolescent, pubmed-meshheading:11757714-Adult, pubmed-meshheading:11757714-Age Factors, pubmed-meshheading:11757714-Aged, pubmed-meshheading:11757714-Antibodies, Monoclonal, pubmed-meshheading:11757714-Antibodies, Monoclonal, Murine-Derived, pubmed-meshheading:11757714-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:11757714-Clinical Trials as Topic, pubmed-meshheading:11757714-Combined Modality Therapy, pubmed-meshheading:11757714-Cyclophosphamide, pubmed-meshheading:11757714-Dose-Response Relationship, Drug, pubmed-meshheading:11757714-Doxorubicin, pubmed-meshheading:11757714-Female, pubmed-meshheading:11757714-Germany, pubmed-meshheading:11757714-Humans, pubmed-meshheading:11757714-Immunotherapy, pubmed-meshheading:11757714-International Cooperation, pubmed-meshheading:11757714-Lymphoma, Non-Hodgkin, pubmed-meshheading:11757714-Male, pubmed-meshheading:11757714-Middle Aged, pubmed-meshheading:11757714-Prednisone, pubmed-meshheading:11757714-Prognosis, pubmed-meshheading:11757714-Radiotherapy, Adjuvant, pubmed-meshheading:11757714-Remission Induction, pubmed-meshheading:11757714-Risk Factors, pubmed-meshheading:11757714-Severity of Illness Index, pubmed-meshheading:11757714-Treatment Outcome, pubmed-meshheading:11757714-Vincristine
pubmed:year	2001
pubmed:articleTitle	Therapeutic strategies for aggressive lymphomas: the trials of the DSHNHL.
pubmed:affiliation	Dept. of Medicine, Saarland University Schooel of Medicine, Homburg/Saar, Germany.
pubmed:publicationType	Journal Article, Review